These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 3490941

  • 1. Stimulating and differentiation factors for human B lymphocytes in systemic lupus erythematosus.
    Martinez-Cordero E, Alcocer-Varela J, Alarcon-Segovia D.
    Clin Exp Immunol; 1986 Sep; 65(3):598-604. PubMed ID: 3490941
    [Abstract] [Full Text] [Related]

  • 2. [Spontaneous production of interleukin-1 and B cell stimulating factors by B cells from patients with systemic lupus erythematosus].
    Hirose T.
    Ryumachi; 1989 Aug; 29(4):277-83. PubMed ID: 2617369
    [Abstract] [Full Text] [Related]

  • 3. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O, Shimizu M, Saeki Y, Kishimoto S, Kishimoto T.
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [Abstract] [Full Text] [Related]

  • 4. Spontaneous production of B cell growth factors by SLE lymphocytes.
    Pelton BK, Denman AM.
    Clin Exp Immunol; 1987 Jan; 67(1):159-66. PubMed ID: 3497742
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. B cell hyperactivity in systemic lupus erythematosus: selectively enhanced responsiveness to a high molecular weight B cell growth factor.
    Delfraissy JF, Wallon C, Vazquez A, Dugas B, Dormont J, Galanaud P.
    Eur J Immunol; 1986 Oct; 16(10):1251-6. PubMed ID: 3095124
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Heterogeneity of B cell responsiveness to interleukin 4, interleukin 6 and low molecular weight B cell growth factor in discrete stages of B cell activation in patients with systemic lupus erythematosus.
    Kitani A, Hara M, Hirose T, Norioka K, Harigai M, Hirose W, Suzuki K, Kawakami M, Kawagoe M, Nakamura H.
    Clin Exp Immunol; 1989 Jul; 77(1):31-6. PubMed ID: 2788539
    [Abstract] [Full Text] [Related]

  • 11. B-cell proliferation and differentiation in systemic lupus erythematosus and mixed connective tissue disease.
    Kallenberg CG, van Dissel-Emiliani F, Huitema MG, Limburg PC, The TH.
    J Clin Lab Immunol; 1988 Jun; 26(2):55-61. PubMed ID: 3264025
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
    Devi BS, Van Noordin S, Krausz T, Davies KA.
    J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF.
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.